Login
Registrati
Reimposta password
Pubblica & Distribuisci
Soluzioni Editoriali
Soluzioni di Distribuzione
Temi
Architettura e design
Arti
Business e Economia
Chimica
Chimica industriale
Farmacia
Filosofia
Fisica
Geoscienze
Ingegneria
Interesse generale
Legge
Letteratura
Linguistica e semiotica
Matematica
Medicina
Musica
Scienze bibliotecarie e dell'informazione, studi library
Scienze dei materiali
Scienze della vita
Scienze informatiche
Scienze sociali
Sport e tempo libero
Storia
Studi classici e del Vicino Oriente antico
Studi culturali
Studi ebraici
Teologia e religione
Pubblicazioni
Riviste
Libri
Atti
Editori
Blog
Contatti
Cerca
EUR
USD
GBP
Italiano
English
Deutsch
Polski
Español
Français
Italiano
Carrello
Home
Riviste
European Pharmaceutical Journal
Volume 66 (2019): Numero 1 (June 2019)
Accesso libero
Hippocampal electrophysiological responses and changes in oxidative stress marker and serum lipid profile to pharmacological and non-pharmacological treatments of high-fat-fructose diet induced metabolic syndrome
D. Micháliková
D. Micháliková
,
B. Tyukos Kaprinay
B. Tyukos Kaprinay
,
M. Sasváriová
M. Sasváriová
,
K. Švík
K. Švík
,
L. Slovák
L. Slovák
,
R. Sotníková
R. Sotníková
,
T. Stankovičová
T. Stankovičová
e
Z. Gáspárová
Z. Gáspárová
| 26 dic 2019
European Pharmaceutical Journal
Volume 66 (2019): Numero 1 (June 2019)
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Sommario
Bibliografia
Autori
Articoli in questo Numero
Anteprima
PDF
Cita
CONDIVIDI
Pubblicato online:
26 dic 2019
Pagine:
32 - 37
Ricevuto:
14 apr 2018
Accettato:
01 giu 2018
DOI:
https://doi.org/10.2478/afpuc-2019-0007
Parole chiave
metabolic syndrome
,
high-fat-fructose diet
,
hippocampus
,
cholesterol
,
oxidative stress
,
rosmarinic acid
,
caloric restriction
© 2019 D. Micháliková et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
D. Micháliková
Slovak Academy of Sciences, Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology,
Bratislava
Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin
Martin
B. Tyukos Kaprinay
Slovak Academy of Sciences, Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology,
Bratislava
M. Sasváriová
Comenius University in Bratislava, Pharmaceutical Faculty, Bratislava
K. Švík
Slovak Academy of Sciences, Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology,
Bratislava
L. Slovák
Slovak Academy of Sciences, Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology,
Bratislava
R. Sotníková
Slovak Academy of Sciences, Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology,
Bratislava
T. Stankovičová
Comenius University in Bratislava, Pharmaceutical Faculty, Bratislava
Z. Gáspárová
Slovak Academy of Sciences, Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology,
Bratislava